Biotechnology Archives - Page 23 of 32

Geron Corporation Up Nearly 10% Today, Here’s Why

The healthcare industry is taking the stock market by storm today. First, we saw InspireMd (NYSEAMERICAN:NSPR) increase more than 20% in the early hours of the trading day. Now, we are looking at Geron Corporation ... [Read]

Corbus Pharmaceuticals Stock Continues to Grow

Jan 26 Siraj Sarwar

Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) continues to impress investors since the start of this year, resulting in share price appreciation of more than 26% in the last month alone. CRBP stock is currently trading around $9 ... [Read]

Two Biotechnology Stocks Trading Higher Today: Capricor Therapeutics and RedHill Biopharma

Jan 26 Caroline Harris

If you’re looking for a particular industry to start investing in, why not consider the healthcare industry? Sure, cryptocurrency or technology might be a tad bit more exciting, but let us not forget that the ... [Read]

Why is Iovance Biotherapeutics Up Nearly 30% Today?

Jan 25 Caroline Harris

January is a month of new beginnings. For some, it means ridding themselves of flaws and putting into action various resolutions moving forward with the new year. For the stock market, it means there are ... [Read]

MannKind Shares Soar, Afrezza and Cash Position in Focus

Jan 25 Siraj Sarwar

MannKind Corporation (NASDAQ:MNKD) shares generated growth of 40% in Thursday’s trade and the stock is up 15% since the start of this year. Although no report accounts for a huge rally in Thursday’s trade, traders ... [Read]

Zymeworks Inc. Stock Soars; Here’s What to Expect

Jan 23 Siraj Sarwar

After declining sharply in the mid of the last year, Zymeworks Inc. (TSX:ZYME) (NASDAQ:ZYME) shares bounced back significantly last month, thanks to strong results related to its Phase 1 dose-escalation study. ZYME stock gained more ... [Read]

Bullish Sentiments are Rising for Fate Therapeutics Stock Price

Jan 23 Siraj Sarwar

Fate Therapeutics Inc. (NASDAQ:FATE) shares continue to extend the momentum in Tuesday trade, supported by investors bullish bets on its future fundamentals and advancement in key pipeline products. Fate Therapeutics shares improved 14% in Tuesday’s ... [Read]

Why Inovio Pharmaceuticals is Up Nearly 30% Today

Jan 23 Caroline Harris

Sure, most of the world might be focusing on the fact that Bitcoin climbed above the $11,000 mark today, despite Goldman Sachs (NYSE:GS) sending out a warning to investors that the digital currency is a ... [Read]

Idera Pharmaceuticals Stock Plunges 20% – Here’s Why

Jan 22 Samara Malkin

Idera Pharmaceuticals Inc. (NASDAQ:IDRA) is under investigation by Levi & Korsinsky, LLP, an established firm in securities litigation. What happened? Earlier in the day, it was announced that Idera Pharmaceuticals would be merging with BioCryst ... [Read]

Are Companies Looking at Acorda Therapeutics as a Potential Takeover Target?

Jan 19 Caroline Harris

Two months ago, New York-based Acorda Therapeutics (NASDAQ:ACOR) had to discard its late-stage drug tozadenant due to five patients passing away in a clinical trial. At the time, this looked like it was going to ... [Read]